Serdar E. Bulun, M.D. is the George H. Gardner Professor of Clinical Gynecology, Friends of Prentice Distinguished Physician in Obstetrics and Gynecology and Director, Division of Reproductive Biology Research at Northwestern University Feinberg School of Medicine.  Dr. Bulun also serves as co-leader of Women’s Cancers and co-leader of the Breast Cancer Research Program at the Robert H. Lurie Comprehensive Cancer Center at Northwestern University, and is a staff physician at Northwestern Memorial Hospital in Chicago, Illinois .  Dr. Bulun is certified by the American Board of Obstetrics and Gynecology (ABOG) in obstetrics and gynecology, as well as in reproductive endocrinology and infertility.

Regarded as one of the world’s most innovative and effective translational researchers among his generation of physician-scientists in obstetrics and gynecology, Dr. Bulun has made substantial contributions to the understanding of reproductive endocrinology and particularly to the role of aromatase and COX-2 in the pathophysiology of endometriosis.  Among other noted achievements, he was the first to describe the full aromatase gene structure and was the first to successfully introduce aromatase inhibitors into the treatment of endometriosis.  Since 2003, Dr. Bulun has been serving as the Director of The Division of Reproductive Biology Research at Northwestern University.  Currently, five independent investigators and approximately 40 research scientists work on translational research related to steroid biochemistry, endometriosis, uterine fibroids, women’s cancers and implantation in this new Division that he founded at Northwestern University.  

Dr. Bulun is involved in many multicenter clinical studies as principal or co-investigator, and serves/has served as a regular member or ad hoc reviewer on numerous National Institutes of Health (NIH) and Department of Defense Breast Cancer Research Program scientific review panels, including:  Integrative and Clinical Endocrinology and Reproduction (ICER); Reproductive Endocrinology (REN); Biochemical Endocrinology (BCE), and other Special Emphasis Panels; Center for Inherited Disease Research (CIDR); Tumor Micro-environment (TME) Study Section; NCI-P01 (breast cancer); Specialized Centers of Research (SCOR) on Sex and Gender Factors Affecting Women’s Health; and, Endocrinology Review Panel.

Dr. Bulun currently serves on several editorial boards including: Journal of Clinical Endocrinology and Metabolism; Steroids; and, Seminars in Reproductive Medicine.  He is also a publication reviewer for numerous international journals such as New England Journal of Medicine (NEJM), Journal of the American Medical Association (JAMA), Journal of Clinical Investigation, Lancet, Cancer Research, Clinical Cancer Research, Molecular Endocrinology, and the American Journal of Obstetrics and Gynecology, among others.  An elected member of the American Society for Clinical Investigation (ASCI), the Society for Gynecologic Investigation (SGI) and the American Gynecological and Obstetrical Society (AGOS), Dr. Bulun has served as an invited expert, program chair, board examiner (Reproductive Endocrinology and Infertility) and/or speaker at more than 50 international and national symposia, conferences, workshops, courses and meetings, and his work has resulted in more than 100  publications worldwide.

Dr. Bulun earned his doctor of medicine from Istanbul University School of Medicine in Istanbul, Turkey.  He was trained as a resident in pathology at the University of Arizona College of Medicine in Tucson .  Subsequently, he completed a four-year residency training in obstetrics and gynecology at State University of New York at Buffalo followed by a subspecialty fellowship in reproductive endocrinology and infertility at the University of Texas Southwestern Medical Center in Dallas, Texas .   After serving as faculty at Parkland Memorial Hospital and UT Southwestern Medical Center in Dallas for six years, he took the position of Director, Division of Reproductive Endocrinology and Infertility at University of Illinois at Chicago as tenured associate professor in 1999.  In 2003, he moved to Northwestern University as professor and founded the Division of Reproductive Biology Research.   In 2007, Dr. Bulun was invested as the George H. Gardner Professor of Clinical Gynecology at Northwestern University.  

Steven R. Goldstein, M.D. is Professor of Obstetrics and Gynecology, Director of Gynecologic Ultrasound and Co-Director, Bone Densitometry, Department of Obstetrics and Gynecology, New York University School of Medicine.  Dr. Goldstein is certified by the American Board of Obstetrics and Gynecology (ABOG), the North American Menopause Society (NAMS) and the American Society of Clinical Densitometrist (ASCD).

Dr. Goldstein’s academic and research interests include:

• Ultrasound in gynecology
• Gender-specific medicine
• Selective estrogen receptor modulation (SERM) for postmenopausal women’s health
• Clinical management of perimenopausal and menopausal women
• Diagnosis, prevention and treatment of osteoporosis
• Female sexual dysfunction
• Breast cancer chemoprevention
• Prenatal genetic diagnosis in recurrent pregnancy loss
• Postgraduate education

Dr. Goldstein has served as principal site investigator and/or principal investigator for numerous clinical trials in the area of women’s health.

He currently serves on numerous editorial boards including:  International Journal of Obstetrics and Gynecology, American Journal of Obstetrics and Gynecology, Fertility and Sterility, Journal of Ultrasound in Obstetrics and Gynecology, Journal of Diagnostic Medical Sonographers, Journal of Clinical Ultrasound, Journal of the North American Menopause Society and Journal of Ultrasound in Medicine.  Additionally, Dr. Goldstein is a Board Examiner for the ABOG, as well as Chairman, Scientific Paper Review in Gynecology for the American Institute of Ultrasound in Medicine’s annual meeting.

Dr. Goldstein is a member of numerous international and national professional and scientific societies including:  the Board of Governors, First Vice President and current Treasurer, American Institute of Ultrasound in Medicine; President elect, member of the Board of Trustees and Chair, Professional Education Committee, NAMS; and the Gynecologic Practice Committee, American College of Obstetrics and Gynecology (ACOG).  He has lectured at more than 350 international and national symposia, conferences, courses and meetings, and his work has resulted in more than 150 publications.

Dr. Goldstein graduated with honors from Colgate University with a B.A. in biology and received his M.D. from New York University School of Medicine.  He completed his residency in obstetrics and gynecology at Bellevue Hospital Center in New York, New York and conducted post-graduate studies at Parkland Memorial Hospital in Dallas, Texas.

Susan L. Hendrix is Professor of Obstetrics and Gynecology at Michigan State University College of Osteopathic Medicine.  Dr. Hendrix was director and principal investigator of the Women’s Health Initiative at Wayne State from 1994-2007.  She is certified by the American Board of Obstetrics and Gynecology (ABOG).

Dr. Hendrix has served as principal investigator and co-investigator for numerous clinical trials in the area of women’s health, including National Institutes of Health/National Heart, Lung and Blood Institute (NIH/NHLBI), National Institutes on Aging (NIA) and National Cancer Institute (NCI) studies.  She is a member of several Data Safety Monitoring Boards as well a previous examiner for the ABOG.

She currently serves on numerous editorial boards including Journal of the American Medical Association (JAMA), American Journal of Obstetrics and Gynecology, Annals of Epidemiology, Journal of Clinical Endocrinology and Metabolism, Journal of Clinical Outcomes Measurement, Menopause and Obstetrics & Gynecology.  Dr. Hendrix has been an invited lecturer at hundreds of local, national and international symposia, conferences and meetings.  She has published more than 200 journal articles, scientific papers, books and/or book chapters, and has appeared extensively in radio, print and broadcast media.

Dr. Hendrix is a member of numerous international and national professional and scientific associations and advisory boards, including:  American Medical Association (AMA), American College of Obstetrics and Gynecology (ACOG), American Urogynecologic Society, North American Menopause Society (NAMS), American Osteopathic Association (AOA), American Society for Reproductive Medicine (ASRM), Association of Professors of Gynecology and Obstetrics (APGO) and American College of Osteopathic Obstetricians and Gynecologists (ACOOG). 

After receiving her undergraduate degree from Villanova University, Dr. Hendrix conducted graduate studies at the Philadelphia College of Osteopathic Medicine and the Michigan State University College of Osteopathic Medicine where she received her Doctor of Osteopathic Medicine.  She conducted a post-graduate internship at Lansing General Hospital and completed her residency in obstetrics and gynecology at Sparrow Hospital in Lansing, Michigan. 

Santiago Palacios, M.D. is Director of the Palacios Institute of Women’s Health and President of the Spanish Foundation for Women and Health.  He also serves as Chairman of the Council of Affiliated Menopause Societies of the International Menopause Society (CAMS) and President of the Ibero American Society of Osteoology and Mineral Metabolism (SIBOMM).  He is Past-President and Honorary Member of the Spanish Menopause Society.

Dr. Palacios’ academic and research interests focus on women’s health, with particular emphasis in the areas of menopause, osteoporosis and female sexual dysfunction.  Dr. Palacios has served as principal investigator in more than 50 clinical trials in the area of women’s health.

He currently serves as Editor-in-Chief of Revista Iberoamericana de Revisiones en Menopausia and serves on numerous editorial boards including Maturitas Journal, Climacteric Journal and Women’s Health Journal.

Dr. Palacios is a member of numerous international and national professional and scientific societies including:  Founder of the first Menopause Unit in Spain, at the Foundation Jimenez Diaz; Founder Member of the European Menopause Society; Founder Member and General Secretary of the Spanish Menopause Society; member of the Executive Committee of the Spanish Association of Osteoporosis and Bone Metabolic Diseases; member of the European Menopause an Andropause Society and ex-Board Member; Board Member of the International Menopause Society; Member of the Association of Gynaecologists and Obstetricians; Member of the Scientific Committee for the North American Menopause Society; Member of the Board of the European Society of Gynaecology (2005-2007); Congress President for the 12th World Congress on the Menopause, Madrid.

He has lectured at more than 800 international and national congresses, courses and meetings, and his work has resulted in more than 330 publications.

Dr. Palacios received his degree in medicine at the Complutense University of Madrid, where he also received his doctorate with honors ‘cum laude’ as Specialist in Gynaecology and Obstetrics.   His post-graduate work includes: Doctor “Honoris Causa” by the American University Nordestana, 1991; Doctor “Honoris Causa” by the Mayor, Real y Pontificia University of San Francisco Xavier de Chuquisaca, Bolivia, 2001; Doctor “Honoris Causa” by the Pacífico University, Asunción, República de Paraguay, 2003; Grant for extended studies abroad at the Conchita Rabago Foundation; member of Lister Hospital, King’s Hospital and Dulwich Hospital of London.

David Portman, M.D., is Director and Principal Investigator of the Columbus Center for Women's Health Research.  Dr. Portman is also a Clinical Instructor at The Ohio State University.  He has conducted over 100 clinical studies in areas of contraception, osteoporosis, menopause, endometriosis, sexual dysfunction and urologic health in female patients.  He has a private gynecology practice and regularly performs gynecologic and urogynecologic surgery.  
 
Dr Portman is a fellow of the American College of Obstetricians and Gynecologists (ACOG) and diplomat of the American Board of Obstetrics and Gynecology.  He is a member of many professional societies, including the Association for Reproduction Health Professionals, the North American Menopause Society, and the International Menopause Society.  He has published his research in peer-reviewed journals and presented results at numerous national conferences.  His consulting and lecturing across the country gives him unique insight into national trends in health care delivery and new therapies.  Dr. Portman has experience in all aspects of drug development from phase II trials to marketing.  He sits on numerous advisory boards to the pharmaceutical industry.

Dr. Portman received a B.A. from Northwestern University and his M.D. from Ohio State University.  Dr. Portman completed his residency in obstetrics and gynecology at Ohio State University Hospitals.

Richard J. Santen, M.D. is Professor of Medicine, Division of Endocrinology and Metabolism, University of Virginia School of Medicine and the Evan Pugh Professor of Medicine at The Pennsylvania State University.  A noted scholar and researcher, Dr. Santen has received numerous academic awards including:  Special Research Fellowship Award from the National Institutes of Health (NIH), The Fogarty Senior International Fellowship Award, The Faculty Scholar Award from Pennsylvania State University, The Susan G. Komen Foundation Brinker International Award for Breast Cancer Clinical Research, The Robert H. Williams Distinguished Leadership Award from The Endocrine Society, and The William McGuire Memorial Lectureship, the San Antonio Breast Cancer Symposium.  Dr. Santen is board certified in internal medicine and endocrinology.

An expert in benign breast diseases, Dr. Santen has contributed to the development of various endocrine treatments of breast cancer, particularly to the development of aromatase inhibitors. Working with a group of National Cancer Institute-sponsored researchers, he showed that estrogen could cause gene mutations that result in breast cancer. He currently investigates the basic mechanisms whereby estrogens cause breast tumor growth and is developing tools with which to evaluate the need for estrogen treatment in menopausal women.  In this context, he is the lead author of the group of 24 experts asked by the Endocrine Society to develop their Scientific Statement on Menopausal Hormone Therapy. Dr. Santen is currently and has been involved as principal site investigator and/or principal investigator for numerous multi-center clinical trials in the area of oncology, endocrinology and women’s health.  These include studies on behalf of the United States Public Health Service (USPHS), NIH, World Health Organization and the Department of Defense’s Program for Breast Cancer Research, among many others.

He currently serves as the Associate Editor for Breast Cancer Research and serves on the editorial boards for Steroids, Women and Cancer, Journal of Enzyme Inhibition and the Polish Journal of Endocrinology.  Dr. Santen also serves as an Ad Hoc Reviewer for numerous publications including:  Science, Journal of Clinical Investigation, Clinical Endocrinology, Endocrinology, Metabolism, European Journal of Cancer and Oncology, Annals of Internal Medicine, American Journal of Physiology (Endocrine Section) and Psychoneuroendocrinology.

Dr. Santen is a member of numerous international and national professional and scientific societies including:  the Society for the Study of Reproduction (SSR), the American Federation of Clinical Research (AFCR), The Endocrine Society, Fellowship in the American College of Physicians (ACP), the American Clinical and Climatological Association (ACCA), the American Society of Andrology (ASA), the American Society of Breast Diseases (ASBD), the American Society of Clinical Investigation (ASCI), the Association of American Physicians (AAP), and the American Society of Clinical Oncology (ASCO).   Additionally, Dr. Santen currently serves a member of the Women’s Health Council of the Hormone Foundation, and a Council member and member of the International Task Force Committee of The Endocrine Society.  He has lectured at hundreds of international and national symposia, conferences, courses and meetings, served as an editor for many books and chaired and/or participated in numerous medical school activities including the development of the audio-visual teaching program in clinical endocrinology at the University of Virginia School of Medicine.  Dr. Santen’s work has resulted in more than 425 publications, including peer-reviewed journal articles, book chapters and medical textbooks.

Dr. Santen graduated from Holy Cross College with an A.B. and received his M.D. from the University of Michigan, Ann Arbor, Michigan.  After completing his internship and assistant residency at New York Hospital, Cornell Medical Center in New York, Dr. Santen completed his senior residency at the University of Michigan Hospital in Ann Arbor, Michigan.  Dr. Santen also received fellowship training in endocrinology at the US Public Health Service Hospital in Seattle, Washington. 

Dr. Simon is Clinical Professor of Obstetrics and Gynecology at the George Washington University in Washington, D.C.  Dr. Simon maintains a private practice of reproductive endocrinology and infertility located at 1850 M St., NW, Washington, D.C., and is Medical Director of the Women’s Health & Research Consultants®.  Dr. Simon is certified by the American Board of Obstetrics and Gynecology in both obstetrics and gynecology, and reproductive endocrinology and infertility.  He is also certified by the International Society for Clinical Densitometry (ISCD; CCD), directs a bone densitometry center, and by the North American Menopause Society, as a Certified Menopause Practitioner (NCMP).

Dr. Simon received his M.D. degree from Rush Medical College (1974-1978) and completed his internship and residency in Obstetrics and Gynecology at the George Washington University Hospital (1978-1982).  He completed his fellowship training in reproductive endocrinology and infertility at Harbor-UCLA Medical Center (1982-1985).  Dr. Simon then became Assistant Professor of Obstetrics and Gynecology at the Jones Institute for Reproductive Medicine in Norfolk, Virginia (1985-1987).  He served as Chief of the Reproductive Endocrinology and Infertility Division at the Georgetown University School of Medicine (1987-1996) before assuming his current duties.  During his tenure at Georgetown, Dr. Simon was the Biomedical Director of The Institute for Reproductive Health, a cooperative program of the National Institutes of Health and the US Agency for International Development (USAID), and was an adjunct scientist at the National Institutes of Health (NIH).  In addition, he founded and directed the Bone Densitometry Unit and managed the Andrology Laboratory.

Dr. Simon is an established investigator in reproductive endocrinology.   His basic research interest is implantation, specifically, embryo/endometrial signaling and tissue remodeling.  His clinical research focuses on the menopause, particularly osteoporosis diagnosis, prevention and treatment, and hormone replacement therapies, including complementary and alternative approaches, and normal and abnormal female sexual function.  He has established himself as an authority on oral micronized progesterone and the effects of routes of administration on both clinical pharmacokinetics and outcome, and on the impact of androgens on women’s health, the skeleton, and sexuality.  Dr. Simon’s research has been supported by more than 140 research grants and scholarships from a wide range of sponsors, including The NIH, The American Heart Association, The Heinz Foundation and the pharmaceutical industry. 

Dr. Simon is a former President and member of the Board of Trustees, the Professional Education, and the Menopause Practitioner Exam writing committee (Chairman) of the North American Menopause Society (NAMS). He is also a former member of the Board of Trustees, the Public Policy, Finance and Management (Chairman) Committees of the International Society for Clinical Densitometry (ISCD).  Dr. Simon is a past President of the Washington Gynecologic Society. Dr. Simon is a current member of the Board of Directors of the International Society for the Study of Women’s Sexual Health (ISSWSH). A short-list of his other honors and achievements includes being selected to “Top Washington Physicians,” America’s Top Obstetricians and Gynecologists, and “The Best Doctors in America.” He is an author or co-author on more than 230 articles, chapters and proceedings, including several prize-winning papers, as well as more than 180 published abstracts.  Dr. Simon is coauthor of the paperback book: Restore Yourself: A Woman’s Guide to Reviving Her Sexual Desire and Passion for Life.  He serves as an ad hoc reviewer for numerous journals, including The American Journal of Obstetrics and Gynecology, The Biology of Reproduction, Endocrinology, Fertility and Sterility, The International Journal of Fertility, The Journal of Bone and Mineral Research, The Journal of Clinical Endocrinology and Metabolism, and The Journal of Clinical Investigation.  He sits on the editorial board of Menopause, the official journal of the North American Menopause Society.